Farmaceutisch bedrijf kiest om in Australië te produceren, om de economie thuis te stimuleren

Sasmar, een Australisch biotechnologisch bedrijf, heeft vandaag aangekondigd dat alle productie van zijn familieplanningslijnen naar de Australische markt is verplaatst.

Sasmar, an Australian biotechnology company, announced today that is has moved all manufacturing of its family planning lines to the Australian market. Sasmar CEO John-Michael Mancini said, “With many Australians concerned by the slump in the economy, and worried about their jobs, their mortgages, their bills and taking care of their children, we have moved manufacturing to add value locally. We are pleased about the new jobs this move has created in the Australian market.” Sasmar, an Australian biotechnology company, announced today that is has moved all manufacturing of its family planning lines to the Australian market. Sasmar CEO John-Michael Mancini said, “With many Australians concerned by the slump in the economy, and worried about their jobs, their mortgages, their bills and taking care of their children, we have moved manufacturing to add value locally. We are pleased about the new jobs this move has created in the Australian market.” 

 
Martin White, partner of accounting firm Jacoby Cameron & Co said, “Australia’s $42 billion recession-fighting stimulus package will see more than seven million Australians receiving $900 cash handouts from today. To inject this money into the Australian economy we must look at buying Australian made products." 
 
Mr Mancini said that consumers should be checking labels to see where products are made. "Australian made products are usually of better quality and the money stays here," he said.
 
Labeling that includes ‘Made in Australia’ is injecting money into the national economy.
 
“Amongst our social circles someone has lost their job, people are questioning if they will be next," said mother of two Jennifer Johnstone of St Ives. "it is fantastic to see companies thinking about how their decisions affect the average Australian."
 
Deel deze post
​ ​ ​
Archiveren
Australisch farmaceutisch bedrijf breekt de barrières naar de bevruchting voor zou de wereld over de wereld zijn
Het Australische farmaceutische bedrijf Sasmar heeft hun bevruchtingsproduct vrijgelaten na drie jaar ontwikkeling in samenwerking met vruchtbaarheidsspecialisten van gerespecteerde universitaire ziekenhuizen in de Verenigde Staten.
​